Naxpar Medicamentos LLP - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAF-6828 Incorporated 10 February 2016 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
10 yrs
Est. 2016
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Mumbai
ROC office
Incorporated
10 Feb 2016
Date of incorporation
Entity type
LLP
As registered with MCA

About Naxpar Medicamentos LLP

Data last updated:

Naxpar Medicamentos LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 February 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAF-6828.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners Binoy Baiju Shah and Ami Mihir Shah.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Gala No 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.

Court records list 2 cases involving the LLP, including 2 filed by the LLP.

Company details

LLPIN AAF-6828
Incorporation Date 10 February 2016
Total Obligation of Contribution β‚Ή1 Lakh
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

Naxpar Medicamentos LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    Gala No 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Naxpar Medicamentos LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Naxpar Medicamentos LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Naxpar Medicamentos LLP, buy the company report.

Designated partners of Naxpar Medicamentos LLP

Naxpar Medicamentos has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Binoy Baiju ShahDesignated Partner16 Mar 20188 Years 7 MonthsCurrent
Ami Mihir ShahDesignated Partner16 Mar 20188 Years 7 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Naxpar Medicamentos LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Naxpar Medicamentos LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Naxpar Medicamentos LLP has 4 designated partner changes on record since 2018: 2 appointments and 2 cessations. The latest: Mihir Prakash Shah ceased to be Designated Partner on 01 Apr 2018.

AGM
Naxpar Medicamentos Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Naxpar Medicamentos Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Mihir Prakash Shah ceased to be Designated Partner.
Ceased
Punit Chunilal Thakrar ceased to be Designated Partner.
Appointed
Ami Mihir Shah was appointed as Designated Partner.
Appointed
Binoy Baiju Shah was appointed as Designated Partner.
Incorporation
10 Feb 2016
Naxpar Medicamentos Llp was registered on 10 Feb 2016 with Roc Mumbai & aged 10 years 8 months as per MCA records.

Frequently asked questions

Naxpar Medicamentos is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 February 2016 (10+ years old) and is registered under LLPIN AAF-6828.

Naxpar Medicamentos has 2 current designated partners:

The latest financial statements of Naxpar Medicamentos on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Naxpar Medicamentos is AAF-6828. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Naxpar Medicamentos has 2 court cases on record: 2 filed by the LLP.

Naxpar Medicamentos was incorporated on 10 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.

Mihir Prakash Shah ceased to be Designated Partner on 01 Apr 2018. Punit Chunilal Thakrar ceased to be Designated Partner on 01 Apr 2018. Ami Mihir Shah was appointed as Designated Partner on 16 Mar 2018. Naxpar Medicamentos has 4 designated partner changes on record in total.

The registered office of Naxpar Medicamentos is at Gala No 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.

Naxpar Medicamentos operates in the pharma industry, in the drug formulation and development segment.

Naxpar Medicamentos can be reached at its registered office: Gala No 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.